
News|Articles|July 1, 2024
Gibcoᵀᴹ CHO Cell Culture Solutions for Biomanufacturing
Author(s)Thermo Fisher Gibco ᵀᴹ
Fact checked by: Thermo Fisher Scientific
Gain access to essential strategies and solutions for optimizing your CHO cell culture workflow. This exclusive resource offers valuable insights and practical guidance tailored to the challenges of scaling up monoclonal antibody manufacturing with CHO cells.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Top 10 BioPharm International Articles of 2025
2
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
3
Biopharma’s 2025 Transformation: A Recap of Our Top 10 Articles
4
AI, CRISPR, and mRNA Driving Biotech’s Smartest Decade Yet
5